Surgery Partners Financials
| SGRY Stock | USD 24.39 0.03 0.12% |
Surgery |
Please note, the imprecision that can be found in Surgery Partners' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgery Partners. Check Surgery Partners' Beneish M Score to see the likelihood of Surgery Partners' management manipulating its earnings.
Surgery Partners Stock Summary
Surgery Partners competes with Pennant, Ensign, Encompass Health, Healthcare Services, and Enhabit. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 8300 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US86881A1007 |
| CUSIP | 86881A100 |
| Location | Tennessee; U.S.A |
| Business Address | 340 Seven Springs |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.surgerypartners.com |
| Phone | 615 234 5900 |
| Currency | USD - US Dollar |
Surgery Partners Key Financial Ratios
| Return On Equity | 0.0036 | ||||
| Return On Asset | 0.0401 | ||||
| Target Price | 31.91 | ||||
| Beta | 2.74 |
Surgery Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Surgery Partners's current stock value. Our valuation model uses many indicators to compare Surgery Partners value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgery Partners competition to find correlations between indicators driving Surgery Partners's intrinsic value. More Info.Surgery Partners is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 11.14 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgery Partners' earnings, one of the primary drivers of an investment's value.Surgery Partners Systematic Risk
Surgery Partners' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Surgery Partners volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Surgery Partners correlated with the market. If Beta is less than 0 Surgery Partners generally moves in the opposite direction as compared to the market. If Surgery Partners Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Surgery Partners is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Surgery Partners is generally in the same direction as the market. If Beta > 1 Surgery Partners moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Surgery Partners is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Surgery has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Surgery Partners' financials are consistent with your investment objective using the following steps:- Review Surgery Partners' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Surgery Partners' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Surgery Partners' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Surgery Partners' stock is overvalued or undervalued.
Surgery Partners March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Surgery Partners help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Surgery Partners. We use our internally-developed statistical techniques to arrive at the intrinsic value of Surgery Partners based on widely used predictive technical indicators. In general, we focus on analyzing Surgery Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Surgery Partners's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.67 | |||
| Information Ratio | 0.1092 | |||
| Maximum Drawdown | 23.37 | |||
| Value At Risk | (2.19) | |||
| Potential Upside | 2.92 |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.